Literature DB >> 11490844

Clinical usefulness of the immunostaining of the tumor markers in pancreatic cancer.

T Ichihara1, S Nomoto, S Takeda, H Nagura, J Sakamoto, K Kondo, M Horisawa, A Nakao.   

Abstract

The effect of the rapid immunostaining of gastrointestinal cancer-associated antigens, CA19-9, CEA, DUPAN2, and CA50 was discussed for intraoperative pathological diagnosis of pancreatic cancer. The method can be completed in only 13 minutes with microwave irradiation to accelerate the incubation of the primary antibody. Only 3 seconds of irradiation at 500 W for fresh-frozen sections produced specific antigen staining of greater intensity than that obtained with longer incubation by the conventional method. Preservation of the tissue structure was satisfactory with minimal nonspecific background staining enabling us to diagnose the intrapancreatic spread of cancer. This method was also applied to intraoperative peritoneal washing cytology. As with frozen section biopsy, the sensitivity of intraoperative cytology is greater than by the conventional staining method, which is able to achieve more precise staging of pancreatic cancers. Our rapid immunoperoxidase staining method on the cryostat section of pancreatic biopsy specimens and on cytology samples provides important information to determine an appropriate operative approach for pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11490844

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  4 in total

1.  Serum level of TSGF, CA242 and CA19-9 in pancreatic cancer.

Authors:  Jing-Ting Jiang; Chang-Ping Wu; Hai-Feng Deng; Ming-Yang Lu; Jun Wu; Hong-Yu Zhang; Wen-Hui Sun; Mei Ji
Journal:  World J Gastroenterol       Date:  2004-06-01       Impact factor: 5.742

2.  Development of an ultrasound-emitting device for performing rapid immunostaining procedures.

Authors:  Hideki Hatta; Koichi Tsuneyama; Takashi Kondo; Yasuo Takano
Journal:  J Histochem Cytochem       Date:  2010-02-01       Impact factor: 2.479

3.  The use of a novel MUC1 antibody to identify cancer stem cells and circulating MUC1 in mice and patients with pancreatic cancer.

Authors:  Jennifer M Curry; Kyle J Thompson; Shanti G Rao; Dahlia M Besmer; Andrea M Murphy; Valery Z Grdzelishvili; William A Ahrens; Iain H McKillop; David Sindram; David A Iannitti; John B Martinie; Pinku Mukherjee
Journal:  J Surg Oncol       Date:  2013-01-17       Impact factor: 3.454

4.  Periductal stromal collagen topology of pancreatic ductal adenocarcinoma differs from that of normal and chronic pancreatitis.

Authors:  Cole R Drifka; Jo Tod; Agnes G Loeffler; Yuming Liu; Gareth J Thomas; Kevin W Eliceiri; W John Kao
Journal:  Mod Pathol       Date:  2015-09-04       Impact factor: 7.842

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.